Please login to the form below

Not currently logged in
Email:
Password:

premature ejaculation

This page shows the latest premature ejaculation news and features for those working in and with pharma, biotech and healthcare.

Forest Labs agrees $1.46bn deal to buy Furiex

Forest Labs agrees $1.46bn deal to buy Furiex

as well as Priligy (dapoxetine) for premature ejaculation.

Latest news

  • Menarini launches urology campaign in Greece Menarini launches urology campaign in Greece

    Menarini is supporting a new awareness initiative to educate men about premature ejaculation. ... women's satisfaction during sex, along with a range of information on premature ejaculation.

  • Menarini to raise awareness of sexual dysfunction Menarini to raise awareness of sexual dysfunction

    The new campaign – 'Firing Too Quickly' – is designed to raise awareness of premature ejaculation. ... We are delighted to launch 'Firing Too Quickly' and hope to support men (and their partners) in the management of premature ejaculation," commented

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    backed for the treatment of primary premature ejaculation in adult men.

  • Pharma deals for May 2012 Pharma deals for May 2012

    Licence. Priligy for premature ejaculation (launched/ P3). 75. Evotec / Zhejiang CONBA Pharmaceutical (b).

  • Race to recovery

    Plethora. Plethora Solutions is in the news as the biotech company announced highly successful results for a final US phase III trial for PSD502, its premature ejaculation spray.

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics